Uppsala and Luzern, September 2021. Navinci Diagnostics AB and Lucerna-Chem AG have entered a distribution agreement for the Swiss market.
”Switzerland is an important market for Navinci and Lucerna-Chem is an excellent organization for us to partner with as they have a strong presence in the region, customer base, and network. We much look forward to working closely with Lucerna-Chem to bring the NaveniTM proximity ligation assay kits to the Swiss life science research and pharma industry.”
Robert Gunnarsson, CEO Navinci Diagnostics AB
”The NaveniTM product line, which enables our customers to study the interplay of proteins in tissues and cells accurately, complements very well our broad portfolio of antibodies and research reagents. The Navinci team is dedicated to work closely with their customers and continue to innovate the field of spatial biology, which fits perfectly with our way of working.”
Adriano Tonini, COO Lucerna-Chem
Navinci (formerly known as Olink Bioscience) is a Swedish life science company that develops and market proximity ligation immunoassays to monitor proteins, their interactions and modifications directly in individual cells and tissue samples (in situ) to understand biology and reveal the responses to disease and drug treatment.
Lucerna-Chem was established in 1978 as a scientific retailer. Today the company has become one of the leading distributors in Switzerland. Headquartered in Luzern, Lucerna-Chem works closely with many innovative manufacturers to provide high-quality diagnostic and research reagents for cell biology, molecular biology, microbiology, biochemistry, immunology, and histology.
Visit us at
